MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dopamine"

  • 2018 International Congress

    Functional connectivity changes in relation to dopaminergic decline in Parkinson’s over time: A resting-state fMRI and 11C-PE2I PET imaging study

    W. Li, N. Lao-Kaim, A. Roussakis, A. Martín-Bastida, N. Valle-Guzman, G. Paul, E. Soreq, R. Daws, T. Foltynie, R. Barker, A. Hampshire, P. Piccini (London, United Kingdom)

    Objective: To evaluate the functional connectivity patterns of basal ganglia subdivisions in relation to dopamine transporter density and motor features in patients with PD at…
  • 2017 International Congress

    Pharmaeconomic study of the treatment of advanced Parkinson’s disease.

    F. VIVANCOS-MATELLANO, A. SANZ, J.U. MIRÓ, J. CADAVID, A. RUÍZ, N. SOLER (Madrid, Spain)

    Objective: Conduct a comparative pharmacoeconomic analysis of the use of  subcutaneous apomorphine infusion pump (SAIP),   continuous levodopa/carbidopa duodenal infusión (LDI) and deep brain stimulation (DBS). Background:…
  • 2017 International Congress

    Curcumin I protect against copper induced neurobehavioral features of Parkinson’s disease in rat

    A. Abbaoui, O. EL Hiba, H. Gamrani (Marrakech, Morocco)

    Objective: evaluate the impact of acute Cu intoxication (10 mg/kg B.W. i.p) for 3 days on the dopaminergic system and locomotor performance, together with the…
  • 2017 International Congress

    Spinal cord stimulation reduces freezing of gait and improves gait in advanced Parkinson’s disease

    O. Samotus, N. Kumar, S. Memar, M. Jog (London, ON, Canada)

    Objective: The primary objective was to investigate the therapeutic effect of spinal cord stimulation (SCS) on gait dysfunction including freezing of gait (FOG) in advanced…
  • 2017 International Congress

    Intention Awareness in Parkinson’s Disease

    S. Di Costa, E. Barow, C. Moll, U. Hidding, O. Fründt, C. Gerloff, R. Erro, M. Pötter-Nerger, C. Buhmann, P. Haggard, C. Ganos (LONDON, United Kingdom)

    Objective: To investigate the role of dopamine in intention awareness of voluntary actions in patients with Parkinson’s Disease (PD). Background: Underactivation of the SMA due…
  • 2017 International Congress

    Imbalance between dopaminergic and cholinergic neurotransmission following rotenone administration suggestive of Parkinson’s-like symptoms in male rats

    S. Madiha, S. Haider (Karachi, Pakistan)

    Objective: In the present study we analyzed rotenone-induced gait abnormalities, muscular weakness and locomotor deficits in rats. The study also evaluated the effects of rotenone…
  • 2017 International Congress

    Basal Ganglia Circuits for Motor and Behavioral, Emotional Performances

    F. Fujiyama (Kyotanabe, Japan)

    Objective: The present study aimed to identify which neurons in the basal ganglia (BG)  target dopaminergic or GABAergic neurons in SN pars compacta (SNc) or…
  • 2017 International Congress

    Rice bran extract against animal model of Huntington’s disease: Possible role of neurotransmitters

    P. Kumar, N. Kaur (Bathinda, Punjab, India)

    Objective: The present study has been designed to explore the effect of rice bran extract against 3-NP induced neurotoxicity in rats.  Background: Huntington’s disease (HD)…
  • 2017 International Congress

    MitoQ and Reduced Glutathione Protects Against Dopamine Induced Brain Mitochondrial Electron Transport Chain Inhibition During Extended In Vitro Incubation: Involvement of Free Radicals and Quinone Products

    A. MAITI (Bengaluru, India)

    Objective: To study the impact of MitoQ and GSH against DA induced rat brain mitochondrial electron transport chain inhibition during extended in vitro incubation. Background:…
  • 2017 International Congress

    Evaluation of serum sestrin protein in Parkinson’s disease: a plausible diagnostic marker

    S. Dey, N. Rai, A. Singh, S. Shekhar, A. Dey (New Delhi, India)

    Objective: In this study, we evaluated the concentrations of sesn1 and sesn2 in the serum of 50 PD patients and 60 elderly controls. Aging is…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 24
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • An atypical and interesting feature of Parkinson´s disease
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley